Consideration of an individual for membership in the University of Arizona Cancer Center requires a major interest in promoting the mission of the UArizona Cancer Center.
There are two membership categories – Member and Associate.
Full-time faculty who serve as PI or Project Leader of cancer-relevant peer-reviewed research grants; team science investigator (i.e., radiology, pathology) who is typically listed as co-investigator (e.g., >20% on multiple cancer grants), or
A leader in cancer research as evidenced by serving as:
- PI of interventional cancer trial that is investigator-initiated and institutionally funded, Or
- PI of an industry-sponsored trial for which the member was a primary scientific contributor to the trial’s design, implementation, and monitoring, Or
- Site PI of a multi-site interventional investigator-initiated trial initiated at another center that accrues at least 5 subjects a year at the Cancer Center, Or
- Holds national leadership position in NCI National Clinical Trials Network studies (National PI or Study Chair, PI on U10 grant, NCTN (or nationally recognized consortium) Committee Chair, Or
New recruit or investigator in cancer research (4-year initial term) or researcher active in another field and has gained interest in pursuing cancer-relevant research
- Faculty who do not meet the criteria to be included in the CCSG application but are actively involved in the Cancer Center's overall research efforts. Associate Members must meet the following criteria: Not involved in cancer research but is actively engaged in patient care or plays a leadership role (e.g., Shared Resource Director, physician leader) that is critical to the success of the Cancer Center.
* Under exceptional circumstances Members with appointments in other fiscally responsible institutions may be granted membership status as allowed by the sponsor and approved by the Program Leader and the Center Director according to the sponsor guidelines:
“Collaborators from other NCI-designated Cancer Centers or research institutions may become Center and program members. While the funded research projects of these members cannot count toward the funding base of the Program or the Center, these members may have full access to shared resources and developmental funds.”
General Membership Privileges Include:
- Eligibility for research space in Cancer Center buildings under the authority of the Director and the Cancer Center Space Committee
- Membership listing on Cancer Center website
- Access to Shared Resources and Common Equipment and priority use/rate for the following Cancer Center Shared Resources and Developing Research Cores and Services:
- Analytical Chemistry
- Behavioral Measurements and Intervention
- Experimental Mouse
- Flow Cytometry & Human Immune Monitoring Facility
- Tissue Acquisition and Cellular/Molecular Analysis
- Clinical Protocol and Data Management services to including cancer clinical trial support of data management, pre- and post-award support, and protocol development assistance
- Access to pre-award administrative services for multi-investigator, center-wide PPG proposals (P01 and P50s)
- Waiver of registration fees for all Cancer Center-sponsored conferences and retreats
- Notification of available research awards, conferences, and seminars
- Scientific and technical review of proposed research by scientific Program Members
- Increased visibility through the Cancer Center's Public Affairs Office
- Application for developmental funds, pilot project funding, and other special award funding through the Cancer Center
- Acknowledge the CCSG, P30CA023074, in manuscripts and presentations that
- contain results obtained in the CCSG shared resources, or
- receive CCSG supplement funds, or
- pilot projects that are funded by CCSG Developmental funds such as Basic-Clinical Research Partnerships
- All members must actively participate in one of the Cancer Center scientific Programs. This includes but is not limited to authorship of collaborative cancer-related manuscripts, development of new research projects, intra– and inter– programmatic project collaboration, attendance at the Cancer Center Program meetings, sponsored conferences, and seminars.
|Research Program||Program Leaders|
|Clinical and Translational Oncology||William Montfort, PhD; Julie Bauman, MD, MPH|
|Cancer Biology||Cynthia Miranti, PhD; Nathan Ellis, PhD|
|Cancer Prevention & Control||Sherry Chow, PhD; Cynthia Thomson, PhD, RD|
- Clinicians must actively participate in established UACC multidisciplinary clinics, tumor boards, disease- oriented teams (DOTs), clinical trial meetings, and other Cancer Center-sponsored clinical and educational programmatic activities.
- All members must submit all cancer-related studies involving humans and/or human specimens/data to the Cancer Center’s Protocol Review and Monitoring Committee (PRMC) prior to submission to the Institutional Review Board. All members’ cancer clinical trials will be routinely reviewed for accrual by the PRMC. The policies and procedures for the PRMC are available on the Cancer Center website.
- All members conducting clinical trials must provide information on cancer clinical studies (patient data, adverse events, protocol deviations, copies of IRB approval letters, revised protocols, audit reports, etc.) regardless of whether or not they utilize the UACC Clinical Trials Office.
- All members conducting clinical trials must provide copies of IRB submissions in regards to serious adverse events, protocol deviations, and audit reports regardless if they utilize the Cancer Center's Clinical Trials Office or not.
- Provide information annually to the UACC, or as required, to fulfill the CCSG applications to the National Cancer Institute including:
- Updated Biosketches (with funding support)
- Updated research interests
- Copies of all published research papers and abstracts
- Information on clinical studies
- Shared Resource service usage
- Progress reports (as applicable)
- Prompt response to surveys from the Office of Administration
- All members must communicate to Program Leaders and Administration any major new cancer-related discoveries and honors
- Participation with communication and development-related activities
- Provide updates for online membership profile as requested by the Cancer Center's Communications Office.
Individual applications are evaluated by Administration, recommended or rejected by the Program Leader, and finally approved by the Cancer Center's Director. Applicants receive notification of the decision on their applications up to ten weeks after application submission.
Review of New Applications and Renewal of Membership
Membership is reviewed annually by the University of Arizona Cancer Center Membership Committee and membership categories may be reassigned based on current review of category criteria and updated member information. Membership reassignment recommendations will then be sent to the University of Arizona Cancer Center Director for approval. The Director has final authority for approval, disapproval, or termination of membership.